Workflow
ZYLOXTB(02190)
icon
Search documents
归创通桥(02190)10月10日斥资123.15万港元回购5万股
智通财经网· 2025-10-10 09:46
智通财经APP讯,归创通桥(02190)发布公告,该公司于2025年10月10日斥资123.15万港元回购5万股股 份,每股回购价格为24.42-24.82港元。 ...
归创通桥(02190) - 翌日披露报表
2025-10-10 09:39
| 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02190 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | 事件 | | 已發行股份(不包括庫存股份)數 目 | | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年10月9日 | | 316,527,613 | | 5,873,131 | | 322,400,744 | | 1). 購回股份 (股份被持作庫存股份) | | | -50,000 | 0.0154 % | 50,000 HKD | 24.6294 | | | 變動日期 2025年10月1 ...
30家港股公司出手回购(10月9日)
Summary of Key Points Core Viewpoint - On October 9, 30 Hong Kong-listed companies conducted share buybacks, totaling 17.93 million shares and an aggregate amount of HKD 621 million [1][2]. Group 1: Buyback Details - Tencent Holdings repurchased 816,000 shares for HKD 551 million, with a highest price of HKD 680.50 and a lowest price of HKD 666.00, bringing its total buyback amount for the year to HKD 60.41 billion [1][2]. - Guoquan repurchased 4.72 million shares for HKD 14.99 million, with a highest price of HKD 3.21 and a lowest price of HKD 3.07, totaling HKD 150.42 million for the year [1][2]. - Jinsong Machine Tool China repurchased 330,000 shares for HKD 11.12 million, with a highest price of HKD 33.98 and a lowest price of HKD 33.40, totaling HKD 17.49 million for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 9 was from Tencent Holdings at HKD 551 million, followed by Guoquan at HKD 14.99 million [1][2]. - In terms of share quantity, Guoquan led with 4.72 million shares repurchased, followed by China Electric Valley and Lianyi Rong Technology with 3.10 million and 2.14 million shares, respectively [1][2]. Group 3: Additional Buyback Information - Notably, the buyback by Zhaogang Group-W on this date marked its first buyback of the year [2]. - The overall buyback activity reflects a trend among companies to utilize share repurchases as a strategy to enhance shareholder value [1][2].
归创通桥(02190)10月9日斥资123.36万港元回购5万股
智通财经网· 2025-10-09 12:50
智通财经APP讯,归创通桥(02190)发布公告,于2025年10月9日斥资123.36万港元回购5万股股份。 ...
归创通桥(02190.HK)10月9日耗资123.4万港元回购5万股
Ge Long Hui· 2025-10-09 12:48
格隆汇10月9日丨归创通桥(02190.HK)公告,10月9日耗资123.4万港元回购5万股。 ...
归创通桥10月9日斥资123.36万港元回购5万股
Zhi Tong Cai Jing· 2025-10-09 12:45
归创通桥(02190)发布公告,于2025年10月9日斥资123.36万港元回购5万股股份。 ...
归创通桥(02190) - 翌日披露报表
2025-10-09 12:38
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 備註: A部已發行股份變動佔有關股份發行前的現有已發行股份數目百分比是依據本公司已發行股份數目總額 (包括本公司全部已發行H 股及全部已發行内資股) (不包括庫存股份)計算 第 1 頁 共 7 頁 v 1.3.0 FF305 第 2 頁 共 7 頁 v 1.3.0 表格類別: 股票 狀態: 新提交 公司名稱: 歸創通橋醫療科技股份有限公司 呈交日期: 2025年10月9日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) ...
归创通桥启动长期股权激励计划 高增长业绩目标彰显公司发展信心
Ge Long Hui· 2025-10-08 12:12
Core Viewpoint - The company has launched a new equity incentive plan aimed at enhancing its market-oriented and long-term incentive mechanisms, driving performance growth, and strengthening its core team's talent advantage [1][2]. Group 1: Equity Incentive Plan Details - The first batch of the equity incentive plan is closely tied to the company's performance growth targets for the next three years, requiring revenue growth of at least 35%, 75%, and 125% by the end of 2025, 2026, and 2027, respectively, compared to 2024 [2]. - The company’s revenue for 2024 is projected to be 780 million yuan, with the incentive plan suggesting potential revenue nearing 1.8 billion yuan within three years, positioning the company among the top tier in the domestic medical device industry [2]. Group 2: Market Context and Competitive Position - The domestic high-value consumables market is undergoing significant changes due to deepening centralized procurement policies, and the company has emerged as the first successful Hong Kong-listed medical device company to transition from 18A to B status, highlighting its growth potential [2]. - The introduction of the equity incentive plan is seen as a crucial internal mechanism to drive the company's rapid growth and strategic breakthroughs [2]. Group 3: Incentive Structure and Market Pricing - The equity incentive plan will utilize restricted stock units (RSUs) with a purchase price of 20 HKD per share, which is below the latest closing price of 25.46 HKD, reflecting a market-oriented approach that is relatively rare in the Hong Kong market [3]. - Typically, Hong Kong-listed companies grant RSUs for free, while the company’s approach aligns employee interests with shareholder interests, demonstrating confidence in future growth [3]. Group 4: Leadership Perspective - The CEO emphasized that the long-term value of the company is derived from continuous creation and collective effort, and the incentive plan reflects the commitment to future growth and value creation for shareholders and employees [4].
归创通桥(02190)10月8日斥资126.66万港元回购5万股
智通财经网· 2025-10-08 11:28
智通财经APP讯,归创通桥(02190)发布公告,于2025年10月8日斥资126.66万港元回购5万股股份。 ...
归创通桥10月8日斥资126.66万港元回购5万股
Zhi Tong Cai Jing· 2025-10-08 11:23
归创通桥(02190)发布公告,于2025年10月8日斥资126.66万港元回购5万股股份。 ...